Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Haatch Ventures
Haatch EIS Fund
7th Jan 2025
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
109: Where are we in the venture capital cycle? | Henry Whorwood of Beauhurst
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Diurnal Group Plc
Life Sciences
Flow of regulatory approvals
By
Dr Martin Hall
13 Aug 2020
Civitas Social Housing PLC
Investor Forum Analysis
By
Mike Foster
12 Aug 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Primary Health Properties
Property
Strong set of results, confirming ongoing rent rises
By
Mike Foster
12 Aug 2020
City of London Investment Group
Financials
Market recovery boosts FUM
By
Dr Brian Moretta
21 Jul 2020
Arbuthnot Banking Group Plc
Financials
2020 interim results: credit robust, rate sensitivity
By
Mark Thomas
20 Jul 2020
Allergy Therapeutics plc
Life Sciences
Record sales and a COVID-19 wildcard
By
Dr Martin Hall
20 Jul 2020
Palace Capital
Property
Encouraging full-year results
By
Mike Foster
14 Jul 2020
Non-Standard Finance
Financials
FY’19 solid; outlook – broad range of outcomes
By
Mark Thomas
13 Jul 2020
Advanced Oncotherapy
Life Sciences
Funded through to clinical events
By
Dr Martin Hall
02 Jul 2020
Bank North
Financials
Bridge over troubled waters
By
Mark Thomas
22 Jun 2020
Incanthera Ltd
Life Sciences
Preparing Sol for commercialisation
By
Dr Martin Hall
19 Jun 2020
Prev
1
...
11
12
13
14
15
...
30
Next
